CORONARY ARTERY DISEASE Original Studies Impact of Severity of Renal Dysfunction on Determinants of In-Hospital Mortality Among Patients Undergoing Percutaneous Coronary Intervention

Background: Chronic kidney disease (CKD) is a known prognostic indicator of poor outcomes following percutaneous coronary intervention (PCI) for coronary artery disease. However, it is unclear whether other predictors of mortality differ among patients with varying degrees of renal impairment. Thus, we aimed to identify determinants of in-hospital mortality which are specific to patients with preserved renal function, moderate CKD, or end stage renal disease (ESRD) on dialysis, undergoing PCI. Methods: The study population included 25,018 patients who underwent PCI between January 1, 2004, and December 31, 2007, at four New York State hospitals. The primary endpoint of the study was in-hospital mortality. Results: A total of 474 (1.9%) patients had ESRD on dialysis, 6,596 (26.4%) had moderate CKD (GFR<60 ml/min/1.73m), and 17,948 (71.7%) had preserved renal function (GFR>60 ml/min/1.73m). Patients with ESRD and moderate CKD were older, more often male, and had higher rates of prior coronary revascularization, peripheral vascular disease, congestive heart failure, prior stroke, and diabetes than those with preserved function. All-cause in-hospital mortality rates were significantly higher in patients with ESRD and moderate CKD compared to patients with GFR >60ml/min/1.73m (2.1% and 1.3%, respectively vs. 0.3%, p < 0.001). In multivariable analysis, ESRD (OR: 3.68, 95% CI 1.62–8.36) and moderate CKD (OR: 2.92, 95% CI 1.91–4.46) were independently associated with higher rates of in-hospital mortality. Independent predictors of mortality were markedly distinct in each group and included female gender and myocardial infarction within the past 72 hr in the ESRD group, versus left ventricular ejection fraction, peripheral vascular disease, congestive heart failure, emergency PCI, and absence of prior PCI in the moderate CKD group and age, prior bypass graft surgery, congestive heart failure, emergency PCI, and absence of prior myocardial infarction in patients with preserved renal function Conclusions: Patients with moderate CKD or ESRD undergoing PCI have an approximately threefold increase in the risk of in-hospital mortality compared with patients with preserved renal function, with radically different mortality predictors existing for varying levels of renal function. VC 2012 Wiley Periodicals, Inc.

[1]  A. Jeremias,et al.  Effect of gender and race on outcomes in dialysis-dependent patients undergoing percutaneous coronary intervention. , 2011, The American journal of cardiology.

[2]  M. Flather,et al.  Low responsiveness to clopidogrel increases risk among CKD patients undergoing coronary intervention. , 2011, Journal of the American Society of Nephrology : JASN.

[3]  O. Morel,et al.  Cardiovascular mortality in chronic kidney disease patients undergoing percutaneous coronary intervention is mainly related to impaired P2Y12 inhibition by clopidogrel. , 2011, Journal of the American College of Cardiology.

[4]  David Dai,et al.  Contraindicated medication use in dialysis patients undergoing percutaneous coronary intervention. , 2009, JAMA.

[5]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[6]  R. Califf,et al.  The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial. , 2008, American heart journal.

[7]  Matthew J Price,et al.  Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation. , 2008, European heart journal.

[8]  J. Ivanov,et al.  Impact of renal insufficiency on angiographic, procedural, and in-hospital outcomes following percutaneous coronary intervention. , 2008, The American journal of cardiology.

[9]  David L. Brown,et al.  The impact of advanced chronic kidney disease on in‐hospital mortality following percutaneous coronary intervention for acute myocardial infarction , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[10]  N. Weissman,et al.  Impact of renal function on coronary plaque morphology and morphometry in patients with chronic renal insufficiency as determined by intravascular ultrasound volumetric analysis. , 2005, The American journal of cardiology.

[11]  H. Krumholz,et al.  Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. , 2003, Journal of the American College of Cardiology.

[12]  A. Jacobs,et al.  Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention. , 2003, The American journal of cardiology.

[13]  Eric J Topol,et al.  Prognostic significance of creatine kinase-MB elevation after percutaneous coronary intervention in patients with chronic renal dysfunction. , 2002, American heart journal.

[14]  G. Stone,et al.  Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure , 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[15]  G. Stone,et al.  Creatine kinase-MB fraction elevation after percutaneous coronary intervention in patients with chronic renal failure. , 2001, The American journal of cardiology.

[16]  I. Palacios,et al.  Effectiveness of and adverse events after percutaneous coronary intervention in patients with mild versus severe renal failure. , 2001, The American journal of cardiology.

[17]  G. Dangas,et al.  The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. , 2000, Journal of the American College of Cardiology.

[18]  D. Baim,et al.  Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting. , 2000, The American journal of cardiology.

[19]  W. O’Neill,et al.  Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. , 1997, The American journal of medicine.

[20]  M. Pencina,et al.  In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. , 2009, JACC. Cardiovascular interventions.

[21]  B. Kasiske,et al.  Excerpts from the United States Renal Data System 2007 annual data report. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.